Does Rallies track congressional trades in DHR?

Yes. Rallies tracks politician and congressional stock disclosures for DHR, including reported purchases, sales, dates, owners, and trade amounts when available.

Is DHR research on Rallies investment advice?

No. Rallies provides research, data, and educational context for DHR. It does not provide personalized investment advice.

DHR (Danaher) Stock Analysis - Politician Trades

Danaher (DHR) is a publicly traded Healthcare sector company. As of May 20, 2026, DHR trades at $171.07 with a market cap of $115.98B and a P/E ratio of 32.77. DHR moved +2.50% today. Year to date, DHR is -27.50%; over the trailing twelve months it is -14.95%. Its 52-week range spans $160.93 to $279.90. Analyst consensus is strong buy with an average price target of $230.40. Rallies surfaces DHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded DHR stock?

Recent politician trading activity in DHR includes disclosures from Michael McCaul, Julie Johnson, Julie Johnson, Julie Johnson, and Ro Khanna. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

DHR Key Metrics

Key financial metrics for DHR
Metric	Value
Price	$171.07
Market Cap	$115.98B
P/E Ratio	32.77
EPS	$5.19
Dividend Yield	0.40%
52-Week High	$279.90
52-Week Low	$160.93
Volume	3.32M
Avg Volume	0
Revenue (TTM)	$24.78B
Net Income	$3.69B
Gross Margin	58.94%

Congressional Trades in DHR

Michael McCaul purchase DHR on Mar 5, 2026 (amount: $15.00K) for Spouse.
Julie Johnson sale DHR on Dec 18, 2025 (amount: $15.00K) for Joint.
Julie Johnson sale DHR on Nov 13, 2025 (amount: $15.00K) for Joint.
Julie Johnson purchase DHR on Oct 7, 2025 (amount: $15.00K).
Ro Khanna purchase DHR on Oct 3, 2025 (amount: $15.00K).

Latest DHR News

Danaher Raises 2026 EPS Guidance to $8.35–$8.55 and Plans Masimo Acquisition — Apr 29, 2026
Danaher drops as Q1 core growth disappoints despite EPS beat and raised guidance — Apr 23, 2026
Danaher drops as Q1 revenue growth disappoints despite EPS beat and raised 2026 outlook — Apr 22, 2026
Danaher Q1 EPS Tops Estimates While Sales Rise 3.5%, PT Hits $245 — Apr 21, 2026
Danaher Tops EPS, Misses Q1 Revenue by $40 M, Eyes Masimo Deal — Apr 21, 2026

Recent DHR Insider Trades

Milosevich Gregory M sold 1.32K (~$274.57K) on Feb 19, 2026.

DHR Analyst Consensus

16 analysts cover DHR: 0 strong buy, 14 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $230.40.

Common questions about DHR

Which politicians traded DHR stock?: Recent politician trading activity in DHR includes disclosures from Michael McCaul, Julie Johnson, Julie Johnson, Julie Johnson, and Ro Khanna. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in DHR?: Yes. Rallies tracks politician and congressional stock disclosures for DHR, including reported purchases, sales, dates, owners, and trade amounts when available.
Is DHR research on Rallies investment advice?: No. Rallies provides research, data, and educational context for DHR. It does not provide personalized investment advice.